Global Compression Therapy Market 2019 Industry Demand, Latest Development, Top Key Players Review, Growth Estimation, Business Strategies, Upcoming Trend and Fast Forward Research

 Market Insight

Market reports associated to healthcare industry recently have been published by Market Research Future states that global compression therapy market is anticipated to display a CAGR growth of 5.2% during the forecast period. The market also gained a valuation of USD 2600 million in 2017, which is also expected to increase by the forecast period. 

Compression therapy is being increasingly incorporated in medical organizations for medicating pain cause in legs. The therapy is practiced evenly over a painful area with the help of compression therapy tools, that are made to worn in forms such as shin sleeves, elbow sleeves, and even masks. Increase in the use of this therapy is paving ways for the market to proliferate.

Market Drivers & Trends

The global compression therapy is majorly driven by rising cases of arthritis that is common among people in the recent generation. Relatively increasing case of sports injuries and accidents have contributed to the growth of market size considerably. Other factors such as technological advancements in compression therapy, presence of a large population of patients and raising awareness regarding the benefits are also anticipated to propel the growth of the global compression therapy market over the forecast period. 

Other factors include regular training of the product to physicians that helps them to understand better about the product, and use of fancy garment for the production of stockings and bandages are growing the market size considerably over the approaching years. 

On the flip side, factors such as lack of information about the indication of disease among the patients and inadequate reimbursement for compression therapy products from government health infrastructures in developed countries is expected to slow down the growth of the global compression market in the forecast period.

Market Segmentation

The global compression therapy market has been segmented on the basis of technique, product, application, and region.

In terms of technique, the market is segmented into static compression therapy and dynamic compression therapy.

In terms of product, the market has been segmented into compression garments, compression pumps, and compression braces. Further, the compression garments segment is classified as compression stockings, compression bandages & wraps, and others.

In terms of application, the market is segmented into varicose vein treatment, deep vein thrombosis treatment, lymphedema treatment, leg ulcer treatment, and others.

Regional Outlook

In the current study, the global compression market is covered into top regions that are the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The significant share of the market is controlled by the Americas owing to the presence of major market players and developed economies like the US and Canada. In this region, SIGVARIS launched diabetic compression socks in 2015 in consideration to provide maximum therapeutic relief for diabetic patients. Apart from this, according to the data proposed by the Centers for Disease Control and Prevention (CDC), approximately 54.4 million US adults had arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia from 2013-2015. It is also projected that an estimated 78 million US adults are projected to have doctor-diagnosed arthritis, by 2040.

In the European region, the global compression therapy market stood at the second position in 2017, which was accredited to the mounting research and development investments. According to the 2018 study available in the Burns & Trauma journal, venous ulcers were recorded to be a common chronic problem in many countries especially in Northern Europe where overall prevalence of this condition was 1%-3% in the population above 65 years of age.

In the Asia Pacific, the market for compression therapy was the fastest in 2017 due to the growing healthcare sector, increasing the entry of the market players, and increasing healthcare expenditure. According to the data proposed by the Australian Institute of Health and Welfare, Australia spent almost USD 181 billion on health in 2016–2017. On the other way, the Middle East and Africa recorded to have the minimum share in the global compression therapy market owing to the low per capita income in the African region.

Key Players

The market players that are a part of the global compression therapy market are 3M, Medtronic PLC, Bio Compression Systems, Inc., BSN Medical, Medi GmbH & Co. Kg, Paul Hartmann AG, Smith & Nephew PLC., Cardinal Health, Inc., Sigvaris, Sanyleg S.R.L., Tactile Medical, Convatec Inc., DJO Global Inc., Getinge AB, Juzo and others.

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

3D Printing Medical Devices Industry Share, Growth Factors, Historical Analysis, Sales Revenue, Development Status, Emerging Opportunities, Competitive Landscape and Regional Forecast to 2027

 3D Printing Medical Devices Market Driven by Growing Geriatric Demographic

Rising Sophistication in 3D Printing Processes to Drive 3D Printing Medical Devices Market

The global 3D printing medical devices market is expected to exhibit a robust 18% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR). The global 3D printing medical devices market is studied in great detail in the report, which includes a thorough analysis of the market’s historical trajectory as well as forecasts for the market’s growth over the forecast period from 2018 to 2023. The leading drivers and restraints affecting the global market are also studied in the report, giving readers a clear and comprehensive picture of the market’s growth prospects over the forecast period. 

Free Sample Copy with Considering Coivd19 Impact on this Market @ https://www.marketresearchfuture.com/sample_request/6830 

3D printing medical devices has become a favored procedure in the healthcare industry due to the various benefits of the 3D printing process. With 3D printing, complicated shapes and parts can be easily produced, with little complication. Advancements in the field of CAD (computer-assisted design) have made 3D printing medical devices easy. This has driven the global 3D printing medical devices market, as widespread use has also led to a reduction in costs, making 3D printed medical devices easier to afford. With 3D printing, the amount of waste is also reduced, as the printing processes are precise and do not allow for the generation of much waste. 

The growing number of geriatrics around the world is likely to be a major driver for the global 3D printing medical devices market. Geriatrics require numerous transplants, such as hip replacements and others, increasing the demand for 3D printed medical devices. The growing acceptance of 3D printed medical devices among geriatrics is likely to remain a major driver for the 3D printing medical devices market, as the geriatric demographic is likely to remain the major consumer of 3D printed medical devices. On the other hand, the high prices of 3D printers and unfavorable reimbursement policies are likely to be the major restraints on the global 3D printing medical devices market over the forecast period. The relative novelty of 3D printed medical devices is the key factor behind this phenomenon, and over time, these complications are likely to be smoothed over. 

Competitive Analysis:

Leading players in the global 3D printing medical devices market include 3T RPD Ltd., Prodways Group, Renishaw plc, Laser GmbH, EOS, Cyfuse Biomedical KK, Bio3D Technologies, Materialise NV, Oxford Performance Materials Inc., Organovo Holdings Inc., Arcam AB, EnvisionTEC, SLM Solutions Group AG, Stratasys Ltd., and 3D Systems Corporation.

Major players in the global 3D printing medical devices market are likely to focus on product development and refinement as the major strategy over the forecast period. 

Segmentation:

The global 3D printing medical devices Industry is segmented on the basis of types, component, technology, application, end use, and region.

By types, the global 3D printing medical devices market is segmented into surgical guides, surgical instruments, prosthetics and implants, and tissue engineering products. The surgical guides segment is likely to hold the largest share in the global 3D printing medical devices market over the forecast period. 

By component, the global 3D printing medical devices market is segmented into system, materials software and services, 3D bioprinters, and 3D printers. The software and services segment is likely to dominate the global 3D printing medical devices market over the forecast period due to the imperative need for CAD and other design principles in 3D printing processes.

By technology, the global market is segmented into 3D printing, droplet deposition, photopolymerization, laser beam melting, electron beam melting, laminated object manufacturing, polyjet technology, and others. Photopolymerization is likely to hold the largest share in the global 3D printing medical devices market over the forecast period. 

By application, the global 3D printing medical devices market is segmented into external wearable devices, clinical study devices, implants, and tissue engineering. The external wearable devices segment holds the largest share in the market. 

By end use, the market is segmented into hospitals, medical and surgical centers, pharma and biotech companies, academic institutions, and contract research organizations. 

Regional Analysis:

The Americas and Europe are likely to hold dominant shares in the global 3D printing medical devices market. 

OBTAIN RESEARCH REPORT DETAILS WITH TOC @ https://www.marketresearchfuture.com/reports/3d-printing-medical-devices-market-6830 

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com 

Anesthesia Monitoring Devices Market share Perceive A Distinctive Growth at a CAGR 10.3% By 2023

The advance anesthesia monitoring devices market has been continuously witnessing outstanding demand. Undeniably, advances in healthcare technology are supporting market growth. These advanced technologies have brought a lot many changes in anesthesia monitoring, which allow sedation levels monitoring during anesthesia, using various electroencephalographic (EEG) indices.

Earlier anesthetists had limited access to monitor vital checks during anesthesia; all they could assess included blood pressure, heart & respiratory rate, body temperature, urine volume, and body movement. However, with the recent technological advances, percutaneous oxygen saturation, end-tidal concentrations of oxygen, carbon dioxide, and inhalation anesthetics can be monitored accurately. 

Such improved abilities of these devices in anesthesia monitoring act as a major driving force pushing their uptake across the medical facilities. Moreover, increasing numbers of surgeries across the globe drive the size of the advance anesthesia monitoring devices market. Additionally, increasing demand for advanced anesthesia monitoring devices from critical care units increases the share of the market on the furthered heights.

Market Research Future (MRFR) states that the global market for advance anesthesia monitoring devices is estimated to register spectacular growth records by 2023, increasing at 10.3% CAGR during the review period (2017-2023). Recent market trends indicate a heavy rise in the shares of the advance anesthesia monitoring devices market. Besides, new developing techniques can also result in aiding substantial growth for the market.

Increasing numbers of surgical procedures in North America, Europe, and other developing nations and raising awareness for healthcare are some of the key growth influencers for the advanced anesthesia monitoring devices market. On the other hand, the higher costs of these devices and inadequate reimbursements provided by the governments, in turn, might act as significant growth impeding factors.

Advance Anesthesia Monitoring Devices Market – Segmentation

MRFR has segmented the market into three main dynamics to widen the scope of understanding,

By Type of Product : Basic/Primary Anesthesia Monitors, Advanced Anesthesia Monitors, Integrated Anesthesia Workstation, among others. 

By End-users : Hospitals, Private Clinics, Ambulatory Services, and others. 

By Regions           : Europe, Americas, Asia Pacific, Middle East & Africa, and Rest-of-the-World.

Global Advance Anesthesia Monitoring Devices Market – Regional Analysis 

North America leads the global advance anaesthesia monitoring devices market, accounting for the worldwide highest adoption across the region. Rising diagnosed chronic disease cases and growing numbers of surgeries to treat them, alongside the rising accident cases requiring surgical processes, drive the growth of the regional market. Besides, factors such as the favorable conditions for research & development and the early uptake of advanced technologies for the development of these devices foster the regional market growth. 

The advance anesthesia monitoring devices in Europe stand accounts for the second-leading market, globally. The European healthcare industry is currently booming owing to the increasing number of medical professionals and growing awareness. The number of various surgeries taking place, specifically in Germany, France, and Italy, are steadily increasing. Augmenting demand for streamlined operations in major health facilities is predominantly driving market growth. 

The Asia Pacific advance anaesthesia monitoring devices market is rapidly emerging as a promising market, globally. The technological growth in India and China is changing the dynamics of healthcare. Moreover, the rapidly improving medical technology and more advancements in improving anesthesia monitoring devices boost the growth of the market.

Advance Anesthesia Monitoring Devices Market – Competitive Analysis

Highly competitive, the advance anaesthesia monitoring devices market appears to be fragmented, with many well-established players inspires a competitive landscape. Players adopt strategies like mergers & acquisitions, collaboration, expansion, and product & technology launch to make sure that the market becomes dynamic. Substantial investments are transpired in R&D to bring betterment in the existing products as well as to develop new ones. 

Major Players:

Players leading the global advance anaesthesia monitoring devices market share include General Electric Company (US), Nihon Kohden Corporation (China), Masimo (US), Medtronic (US), Infiniummedical (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Drägerwerk AG & Co. KGaA (Germany), Sedana Medical AB (Sweden), Smiths Medical (UK), Maquet Holding B V & Co. KG. (Germany), OSI Systems (US), Teleflex Incorporated (US), Getinge AB (Sweden), ResMed (US), Fisher & Paykel Healthcare Limited (New Zealand), Intersurgical Ltd (UK), and Phillips Plastics Corporation. (The Netherland), among others. 

Industry/Innovation/Related News:

December 11, 2019 --- Milestone Scientific Inc. (the US), a medical technology company, announced its partnership with Red One Medical Devices LLC (the US), to distribute its CompuFlo Epidural System to VA and DoD medical facilities worldwide. CompuFlo Epidural Trainer is now available for anesthesia education worldwide. CompuFlo uses real-time Dynamic Pressure Sensing® technology and detects pressure changes that are imperceptible by touches, such as optical, quantifiable pressure and fluid measurements. These pressured are paired with audible feedback to allow anesthesia providers to verify the epidural space has been reached with objective intelligence.

Access Report Details @ https://www.marketresearchfuture.com/reports/anesthesia-delivery-devices-market-1285

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Biosimilars Market Share 2020 Global Market Analysis, Demand, Key Players, Future Growth By 2027

Market Overview:

Biosimilars are biologic medical products that are highly similar to the existing biologic medicines which are complex molecules or mixture of molecules that may be composed of living materials. As per the report that has been recently published by Market Research Future (MRFR).

Market Drivers and Restraints:

Increasing consumer inclination towards biosimilars over generic medicine is majorly driving the global biosimilars market. The high demand for cheap medical products that provide similar result as that of the expensive ones and rise in prevalence of various acute and chronic diseases due to the changing lifestyle, food habits and biological factors are projected to be propelling the growth of the global biosimilars market in the coming years. However, lack of awareness regarding biosimilars and physician skepticism are the primary factors that are likely to hamper the growth of the global biosimilars market. 

Market Segmentation:

The global biosimilars market Share has been segmented on the basis of product, application and manufacturing. Based on product, the biosimilars market is segmented into recombinant glycosylated proteins, recombinant non-glycosylated proteins and others. The recombinant glycosylated proteins segment includes monoclonal antibody (mAb) and EPO. The recombinant non-glycosylated proteins segment is sub-segmented into insulin, growth hormones and others. Based on application, the biosimilars market is segmented into immune diseases, oncology, blood related disorders and others. Based on manufacturing, the biosimilars market is segmented into contract manufacturing and in-house manufacturing.

Regional Analysis:

Geographically, the global biosimilars market has been segmented into four major regions such as North America, Asia Pacific, Europe and the Middle East and Africa. Among these, the Europe region is projecting dominance over the global biosimilars market owing to the rise in research and development activities in the healthcare sector and high healthcare expenditure by the population of this region. With respect to market size, the North America region stands second in the global biosimilars market. The high prevalence of chronic and acute diseases and easy adoption of advanced technology for diagnosis of these diseases in the well-developed healthcare sector is majorly driving the biosimilars market in the North America region. The biosimilars market in the Asia Pacific region is projecting significant growth owing to increasing demand for advanced diagnostic techniques and increasing prevalence of chronic diseases in this region. 

Industry Updates:

In September 2018, Xbrane Biopharma, a biopharmaceutical company, has announced that the board of directors of Xbrane has decided to focus majority of company's development resources to biosimilars from generic drugs. 

In September 2018, Pall, a leading provider of filtration, separation and purification solutions, has announced a strategic partnership of its Pall Biotech business unit and Aetos Biologics, a San Francisco based biosimilar cell-line development company. This collaboration focuses on biosimilar manufacturing solutions.

Key Players:

The prominent players profiled by MRFR in the report on the global biosimilars market are Pfizer Inc. (the U.S.), Teva Pharmaceuticals Industries Ltd. (Israel), Sandoz International GmbH (Germany), Celltrion, Inc. (South Korea), Astra Zeneca (the UK),  Amgen Inc. (the U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Biocon Ltd. (India), Dr. Reddy’s Laboratories Ltd. (India), Novartis (Switzerland), Accord Healthcare (the U.K.), Eli Lilly (the U.S.) and Samsung Bioepis (South Korea).

Read More @ https://www.marketresearchfuture.com/reports/biosimilars-market-1329 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Blog: https://healthcarenews12.blogspot.com/

Clinical Reference Laboratory Market Trends, Global Demand, Growth and Forecast

 Clinical Reference Laboratories Market Overview:

The global clinical reference laboratories market, as described in the report of Market Research Future (MRFR), is expected to rise by attaining 5.8% CAGR during the forecast period (2016-2027). Clinical reference laboratories play an integral part in providing patient care, but its role is equally important in medical researches and laboratory services such as diagnosis, treatment, monitoring, and others. In order to obtain a precise result in short time, clinical reference laboratories help by implementing strategies, exact data collection, and step-wise planning. 

Free Sample Copy With Considering Coivd19 Impact on this Market @https://www.marketresearchfuture.com/sample_request/1190 

The value-based services are gaining much precedence in the recent time which is expected to boost the overall clinical reference laboratories market growth. Hospitals are often outsourcing such diagnosis results to expert companies outside to curb their cost. This could give rise to clinical reference laboratories market. In addition, the technology needed to support such establishments are progressing rapidly owing to which the market can easily expand. Introduction of automation has significantly taken sectors like microbiology and histopathology forward. Genetics and molecular biology are also gaining much from technological advancements. Automation has eased the process of obtaining results which is also a major driving factor for the market’s growth in the coming days.   

Clinical Reference Laboratories Market Regional Analysis:

Depending on the geographic region, MRFR includes, namely the Americas, Europe, Asia-Pacific, and Middle East & Africa to conduct a study on the clinical reference laboratory market. This is to analyze opportunities that would better the market prospect. 

Structural superiority and high investment capability have taken the clinical reference laboratory market of the America’s forward. Especially, due to the presence of the U.S. in the North American region is bolstering growth. The region has the well-structure infrastructure and several products in the pipeline to get the market soaring. Along with Canada, the U.S. is playing a significant role in ensuring the growth of the market. 

Europe ranks second in terms of fetching revenues. The regional market shares similar features like that of the Americas. In addition, the presence of countries like Germany, France, and the U.K. can change the market dynamics as their investment in the sector is considerable. But recent deals with the Brexit could weaken the market. The APAC region is expected to clock the fastest CAGR during the forecast period. The region would benefit much from investment in researches in countries like Japan, China, and India. 

Clinical Reference Laboratories Market Segmental Analysis:

The clinical reference laboratories market gets segmented by service providers and applications as a mode for better analysis. MRFR in their report on it is focusing primarily on the value-based and volume-based data review to get a comprehensive picture of the market. 

Based on service providers, the clinical reference laboratories market can be segmented into stand-alone, hospital-based and clinical-based. The stand-alone segment is expected to gain much from the investments waiting to be introduced in the sector.

Based on applications, the clinical reference laboratories market can be segmented into laboratory medicine, clinical trials, and others. The laboratory medicine segment is expected to grow with a substantial CAGR during the forecast period. Several products in the healthcare sector are also awaiting trials owing to which the clinical trials segment can grow in the coming years. 

Competitive Landscape:

Significant players to impact the global clinical reference laboratories market are ARUP Laboratories, KingMed Diagnostics, Laboratory Corporation of America, Sonic HealthCare Limited, Aurora Diagnostics, Bioreference Laboratories, Synlab International GmbH, Clinical Reference Laboratory, Unilabs, Quest Diagnostics, and others. These companies are making an effort in taking the market ahead by investing substantially in developing strategies. 

Notified Body (NB) and MedTech are planning a reformation in rules and regulations regarding medical devices and in vitro diagnostic regulations (MDR/IVDR). This would substantially push the demand for clinical reference laboratories market as the change in certificates would demand a necessary revamping of the existing standards in infrastructure. 

Click here to get the short-term and long-term impact of COVID-19 on this Market: https://www.marketresearchfuture.com/reports/clinical-reference-laboratories-market-1190 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.l

Elastography Imaging Market Insights 2021: Business Opportunity, Future Scope & Rising Demand By 2027

 Market Analysis 

The global elastography imaging market is estimated to grow at an 11.1% CAGR between 2019-2025, reveals the new Market Research Future (MRFR) report. Elastography, simply put, is a medical imaging mode that maps the stiffness & elastic properties of soft tissue. Owing to its magnificent features, elastography imaging has wide applications in orthopedic and musculoskeletal applications, vascular, urology, obstetrics/gynecology, cardiology, radiology/general imaging, and others.

Numerous factors are adding to the global elastography imaging market growth. Such factors, according to the recent MRFR report, include the growing demand for effective therapies for treating complicated disorders, changes in regulatory policies, increasing incidence of life-threatening diseases, and burgeoning demand for procedures that are minimally invasive to diagnose as well as treat various chronic diseases. 

On the contrary, the high price of systems may limit the global elastography imaging market growth over the forecast period. 

Market Segmentation

The MRFR report provides an inclusive segmental analysis of the global elastography imaging market based on end user, application, and modality. 

By modality, the elastography imaging market is segmented into magnetic resonance elastography (MRI) and ultrasound. Of these, the ultrasound segment will lead the market over the forecast period for the plentiful benefits that it offers. Meanwhile, magnetic resonance elastography will grow at the fastest pace for its increasing adoption rate and wider availability. 

By application, the elastography imaging market is segmented into orthopedic and musculoskeletal applications, vascular, urology, obstetrics/gynecology, cardiology, radiology/general imaging, and others. Of these, radiology/general imaging will dominate the market over the forecast period for the rising prevalence of chronic diseases worldwide. Meanwhile, the cardiology segment will grow at the fastest pace over the forecast period for the increase in the patient population. 

By end user, the elastography imaging market is segmented into research laboratories, diagnostic centers, hospitals and ambulatory surgical centers, and others. Of these, hospitals and ambulatory surgical centers will have a major share in the market over the forecast period. Rising number of hospitals coupled with the increasing number of hospitalizations are adding market growth. Meanwhile, the diagnostic centers will grow at the fastest pace over the forecast period for inclination towards these centers and increased patient preference. 

Regional Analysis 

By region, the global elastography imaging market report covers the growth opportunities and recent trends across Europe, the Americas, the Middle East & Africa (MEA), and the Asia Pacific (APAC). Of these, the Americas will have the lions share in the market over the forecast period. Factors adding to the global elastography imaging market growth in the region include the increasing use of new technology, rising per capita healthcare expenditure, and increasing expenditure by healthcare bodies in research. Canada and the United States are the key contributors in the region for improving reimbursement scenario and a rise in insurance coverage. 

The global elastography imaging market in Europe is predicted to hold the second-largest share over the forecast period for the involvement of top companies, rise in chronic diseases, and the presence of an established healthcare system. 

The global elastography imaging market in the APAC region will have steady growth over the forecast period for the favorable initiatives undertaken by the government for healthcare reforms and the rising prevalence of chronic diseases. Meanwhile, a fall in capital investment may hinder the market growth. 

The global elastography imaging market in the MEA will have a small share during the forecast period for the region’s low disposable income and limited access to medical treatment facilities. 

Key Players

Leading players profiled in the global elastography imaging market report include General Electric Company, Supersonic Imagine, Samsung Electronics (Samsung Medison), Koninklijke Philips N.V., Mindray Medical International Ltd., Resoundant Inc., Hitachi Ltd., Esaote, Fujifilm Holdings Corporation, Siemens AG, and Canon Medical Systems Corporation. 

Industry News

November 2019: SimonMed Imaging is the first to provide advanced screening for fatty liver disease. The VIDA 3T MRI helps to detect fibrosis resulting from fatty liver disease or other chronic liver diseases. It uses MRE (magnetic resonance elastography) that combines sound waves with MRI to develop an elastogram (visual map) to show the stiffness of the body tissue, thus offering radiologists with color contrasted clear visual, maximizing accuracy, and limiting error.

Read More @ https://www.marketresearchfuture.com/reports/elastography-imaging-market-8070 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

 

Global Veterinary Market, Unleashing the Forecast for 2019-2025

 Market Scenario

Market Research Future (MRFR) asserts that the Global Veterinary Vaccines Market is likely to expand at a CAGR of 5.65% during the forecast period (2018-2023). The surging incidences of livestock diseases are likely to favor the market growth. Vaccines help to make animals disease-immune for a specific disease. In terms of biology, vaccination against a certain pathogen mimics the development of naturally acquired immunity by the inoculation of non-pathogenic components of that certain pathogen. Veterinary vaccines are generally used to treat and prevent animal diseases. The market is likely to witness an upsurge owing to the rising spending on companion animals worldwide.

Market Potential and Pitfalls

The surging adoption of pet across the globe and the rising animal related diseases are the top factors encouraging the market growth during the appraisal period. The market players across the world are thus actively working in order to introduce more advanced animal vaccines in the market which is likely to influence its growth. For instance, Boehringer Ingelheim launched two swine vaccines in 2015 in the market against Porcine Reproductive and Respiratory Syndrome. Factors like rising prevalence of livestock diseases, growing adoption of companion animals, technological advancements in animal vaccines, and surging initiatives by the government are contributing to the growth of the market.

Animal vaccines enables controlling the transmission diseases, thereby providing protection to both the animal and human health, which is important considering the public dependency on animals. Animals serve as an important food source, milk, meat, protein, and other commercial products like wool and leather. Some of the most commonly used veterinary vaccines comprises foot & mouth diseases vaccines, rabies vaccines, and equine influenza virus vaccines, which help to prevent the transmission of infectious agents. With the continuous development of vaccines, the market is likely to flourishing. Moreover, the surging investment for R&D of vaccines, which impedes the growth of antibiotic-resistant organism, enhances the animal vaccines market growth. 

On the contrary, inadequate reporting systems and surveillance along with high cost of storage are the top two barriers likely to vitiate the market growth in the long run. Moreover, the dearth of animal health awareness coupled with the possibilities of adverse impacts of such vaccines on animals and human health are likely to hinder its growth during the appraisal period.

Global Animal Vaccines Market: Segmental Analysis

The global animal vaccines market has been segmented on the basis of technology, type, composition, and indications.

By mode of type, the global animal vaccines market has been segmented into poultry vaccines, static porcine vaccines, companion animal vaccines, livestock vaccines, aquaculture vaccines, and others. Among these, the companion animal vaccines are likely to gain to gain prominence in the coming years owing to the increased awareness regarding companion animal vaccination, rising number of pets, surging incidences of zoonotic diseases in human beings, and growing pet ownership.

By mode of technology, the global animal vaccines market has been segmented into inactivated vaccines, live attenuated vaccines, recombinant vaccines, toxoid vaccines, and others. Among these, the live attenuated vaccines are estimated to expand at a significant rate owing to the ease of administration along with the long-term immunity offered by these vaccines.

By mode of indications, the global animal vaccines market has been segmented into parvovirus, foot & mouth disease, reproductive & respiratory syndrome, distemper, and others.

By mode of composition, the global animal vaccines market has been segmented into mono vaccine and combination vaccine.

Regional Insights

Geographically, the animal vaccines market span across regions namely, Europe, America, Asia-Pacific and the Middle East & Africa.

Considering the global scenario, the American region is anticipated to dominate the global market due to the presence of prominent market players and increased pet adoption in developed nations like Canada and the U.S.  As per the American Society for the Prevention of Cruelty to Animals, around 6.5 million companion animals enter the animal shelter every year. North America is a prominent economy, generating the maximum revenue. The rising consumption of milk and meat, the increased awareness associated with the benefits of using animal vaccines, and high adoption of companion animals are influencing the market in this region.

 The European region is likely to occupy the second spot in the global market owing to the surging investments on research and development. For instance, Boehringer Ingelheim declared to reinforce its leading position in the veterinary market in 2018, with almost 70 million euro investment in the biological production and R&D activities.

The Asia Pacific region is estimated to expand at the fastest rate in the global market. The growth has been ascribed to the surging awareness regarding animal health which drives the regional markets. For instance, at the 5th Global Animal Health Conference in 2016, HealthforAnimals association called for greater cooperation among the national governments in order to improve the market access for veterinary medicines.

Industry Updates

April 17, 2018: VEROVACCiNES GmbH has been recently awarded with 3.1 million euro research funding from GO-Bio for a period of 3 year. The support is aims towards the development of yeast-based vaccines.

Competitive Dashboard

The prominent players operating in the global animal vaccines market comprises Biogenesis Bago, Bayer AG, China Animal Husbandry, Boehringer Ingelheim GmbH, Hester, Elanco Animal Health, Indian Immunologicals Limited, Idt Biologika, MSD Animal Health, Merck Animal Health, Tianjin Ringpu, Phibro Animal Health, Zoetis Inc., Vetoquinol, and others.

Read More @ https://www.marketresearchfuture.com/reports/veterinary-animal-vaccines-market-2687 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

3D Printing Medical Market Size, Industry Growth, Revenue Analysis, Developments, Emerging Trends, Future Plans and Regional Forecast to 2027

 As per Market Research Future (MRFR) analysis, the global 3D printing medical devices industry is projected to grow at a CAGR of 18% from 2018 to 2023 (forecast period).

3D printing plays a vital role in the development of medical and dental devices. 3D printing is the most commonly used medical device and, due to its versatility, can also be used for other items, including food, household items, and automotive parts. The 3D printing technology is used to treat various types of therapies, such as hip and jaw titanium replacements, limb prosthetics and plastic tracheal splints, etc. Due to advanced technology and easy use of devices, many doctors prefer 3D printing devices before surgeries of any organ part that may minimize error. A computer-aided design drawing or a magnetic resonance image is a 3D object created from a digital 3D image. The 3D object is formed by creating successive layers of material in which each layer is connected to the previous layer until the object is complete. Various types of materials are used to create a 3D image.

Market Dynamics

The global market for 3D printing medical devices is expected to expand due to growing government spending in the healthcare sector, rising technological developments in 3D printing, easy production of medical devices, and the growing use of 3D printing devices in the healthcare sector. 3D printing plays a crucial role in the medical and dental manufacturing market. This is a very cost-effective and preferred choice for medical device manufacturers for all kinds of medical devices such as prostheses, hearing aids, custom knee, and hip implants. The 3D printing medical devices are expected to show substantial growth during the forecast period due to various technological developments in this field. In addition, a variety of other factors, such as investment in R&D, rapidly growing consumer base, increasing the reach of biomedical applications, have driven market growth.

However, some aspects that may hinder future market growth are unfavorable reimbursement policies, high printer costs, biocompatibility issues for 3D printed medical devices, and limited technical knowledge in medical devices.

Segmentation

The global market for 3D printing medical devices has been segmented into types, components, technology, application, and end-users.

Based on types, the global market for 3D printing medical devices is classified into the segments of surgical guides, prosthetics & implants, surgical instruments, and tissue engineering products. The Surgical Guide is predicted to hold the largest share of the 3D printing market for medical devices in the forecast period. The 3D printing surgical guide is part of operation preparation and offers precise restoration of the implant. The demand for a surgical guide is therefore growing which is a significant factor driving the growth of this market segment.

Based on components, the global market for 3D printing medical devices is divided into materials software & services, 3D printer, and 3D bioprinter. Software & services are projected to register for the largest market share in 3D medical device printing in the forecast period. Growing development of software solutions for the production of high-quality 3D-printed medical products is a primary driver of the growth of the services and software segment.

On the basis of technology, the market for 3D printing medical device is segmented into 3D printing, droplet deposition, laser beam melting, photopolymerization, laminated object manufacturing (LOM), electron beam melting (EBM), polyjet technology and others. Photopolymerization is projected to maintain the largest market share in the 3D printing medical device. 

Depending on the application, the global 3D printing medical device market is segmented into external wearable devices, implants and tissue engineering, and clinical trial devices. The external wearable devices segment retains the largest share of the 3D printing medical devices market in the forecast period.

Depending on end-users, the global 3D printing medical device market is categorized into hospitals, medical and surgical centers, pharmaceutical and biotech firms, academic institutions, and contract research organizations. The segment of medical and surgical centers accounts for the largest share of the 3D printing medical devices market due to an increasingly growing patient population and reduced risk of surgery and infection.

Regional Analysis

The market has been segmented by area across the Americas, Europe, the Asia Pacific and the Middle East and Africa. The market for 3D printing medical device in the Americas has been further broken down into North America and South America, with the North American market split into the USA and Canada. The European market for 3D printing medical devices has been segmented into Western Europe and Eastern Europe. Western Europe has also been listed as Germany, France, the United Kingdom, Italy, Spain, and the rest of Western Europe. The market for 3D printing medical devices in the Asia Pacific has been segmented into China, Japan, India, Australia, South Korea, and the rest of the Asia Pacific. The market for biomaterials in the Middle East and Africa has been segmented into the Middle East and Africa.

North America dominates the market for global 3D printing medical devices over the forecast period. The largest share is due to a growing demand for organ transplantation across the region. Some of the aspects responsible for market growth in this region are attributed to increased government spending to develop advancements in 3D printing technologies and applications.

The second-largest 3D printing medical devices market is projected to be the European market. Market growth in this region can be ascribed to government funding and support for the healthcare sector, combined with increased research and development. In addition, an increasing number of surgeries due to changing lifestyles are leading to the growth of the market in the region.

The Asia Pacific is predicted to be the fastest-growing 3D printing medical device market in the forecast period due to the rising prevalence of chronic diseases, increasing investment in healthcare, growing geriatric population, and the proliferation of market players in the region.

The market in the Middle East and Africa is projected to register for the smallest share of the market for global 3D printing medical devices due to underdeveloped healthcare, lack of technological expertise and inadequate medical facilities.

Key Players 

Some of the prominent players in the market for 3D printing medical devices are SLM Solutions Group AG, 3D Systems Corporations, Stratasys Ltd., EnvisionTEC, Arcam AB, Organovo Holdings, Inc., Materialise NV, Oxford Performance Materials, Inc., Bio3D Technologies, Prodways Group, Cyfuse Medical K.K.EOS GmbHConcept, Laser GmbH, 3T RPD Ltd, Renishaw plc.

Breast Biopsy Market 2023 Industry Overview, Trends, Demand, Key Insights, End-Users, Top Companies, Development Status and Growth Forecast by 2027

 Global Breast Biopsy Market: By Product (Biopsy Needles, Biopsy Tables), Technique Type (Fine Needle Aspiration Biopsy, Core Needle Biopsy), Guidance Technology (Ultrasound-Guided, CT-Guided Biopsy), End-Users (Hospitals, Labs) –Global Forecast Till 2023

Increased cancer detection rates globally have contributed to a rise in biopsy procedures. Market reports connected with the healthcare industry have been presented by Market Research Future which makes reports on other industry verticals that aims to analyze the current market scenarios better. The market is projected to develop at a favorable CAGR rate in the forecast period.

Market Research Future (MRFR) report on the global breast biopsy market is a comprehensive research that provides a detailed overview of the market. The report covers the COVID-19 analysis of the global breast biopsy market and provides a detailed summary of market segments, current trends, growth projections, and market challenges from 2018 to 2023 (forecast period) to identify potential business opportunities.

Free Sample Copy of  With Considering Coivd19 Impact on this Market @ https://www.marketresearchfuture.com/sample_request/6288  

A biopsy is a small operation performed to remove tissue from the area of concern within the body. Breast biopsy is a procedure that involves testing small samples of breast tissue to detect breast cancer. Breast biopsies are performed using minimal invasive biopsy systems due to minimal disfigurement and pain. There are various types of biopsy procedures depending on the technique, such as fine needle aspiration biopsy (FNAB), core needle biopsy (CNB), and vacuum-assisted biopsy (VAB) prescribed by the doctor based on the size, location, and other characteristics of the breast abnormality.

 

Breast Biopsy Market Dynamics

Increased breast cancer prevalence, particularly among women over 35 years of age during menopause (more vulnerable to breast cancer) and increased awareness of breast cancer screening programs, is driving the market growth. Nonetheless, unspecific regulatory concerns, infection risks associated with breast biopsy procedures, and unclear reimbursement policies are factors that hinder market development. In addition, market limitations include the high cost of surgical procedures and the complications involved. Conversely, the advent of technologically advanced and minimally invasive breast biopsy devices is expected to create lucrative opportunities in the untapped market.

 

Breast Biopsy Market Segmentation

The global market for breast biopsy has been segmented based on product, technique type, guidance technology, and end-user.

Based on the product, the global market for breast biopsy has been classified as biopsy wires, biopsy needles, biopsy tables, guidance systems, and others.

Based on technique type, the global market for breast biopsy has been classified into fine needle aspiration biopsy, core needle biopsy, biopsy markers, surgical biopsy, MRI-guided core needle biopsy, sentinel node biopsy, and wire localization. Further, core needle biopsy is divided into needle biopsy, stereotactic core, ultrasound-guided core biopsy, freehand core-needle biopsy, and vacuum-assisted biopsy. Surgical biopsy is divided into incisional biopsy and excisional biopsy.

Based on guidance technology, the global market for breast biopsy has been classified into CT-guided biopsy, ultrasound-guided, mammography-guided magnetic resonance, and other image-guided breast biopsy (PET and thermography).

Based on end-user, the global market for breast biopsy has been divided into hospitals, ambulatory surgical centers, diagnostic centers, and others.

 

Breast Biopsy Market Regional Analysis

Regionally, the global market for breast biopsy has been segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa. 

North America is projected to have the highest market share owing to the early adoption of advanced medical technologies and the continued growth of companies operating in cancer diagnostics. The global market for breast biopsy is primarily based on North America and Europe, which account for more than 50 % of the market share.

The European market is projected to have the second-highest market share, as breast cancer is the most prevalent in the United Kingdom and Belgium. As per Cancer Research UK, 55122 new cases of invasive breast cancer were diagnosed in 2015.

The Asia Pacific region is also expected to rise in the near future due to access to appropriate treatment facilities, growing demand for advanced technologies, higher acceptance rates, growing government initiatives, and increasing healthcare expenditure.

The global breast biopsy market in the Middle East and Africa is projected to account for the lowest share of the global breast biopsy market due to underdeveloped healthcare, lack of technical knowledge, and inadequate medical facilities.

 

Breast Biopsy Market Key Players

Some of the major players identified by MRFR in the global breast biopsy market are Leica Biosystems, NuVue Therapeutics, Argon Medical Devices, Inc., C.R. Bard Inc., Becton, Dickinson and Company, Devicor Medical Products Inc. Hologic Inc. Argon Medical Devices, Encapsule Medical Devices LLC., Cook Medical Incorporated, Johnson & Johnson, Galini SRL, Intact Medical Corporation, Hologic Inc., Conceptus INC, Karl Storz GmbH & Co. Kg, GE Healthcare.

Browse Complete Report @  https://www.marketresearchfuture.com/reports/breast-biopsy-market-6288 

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com